MedTrace Logo

Ivermectin as a Novel Therapy in COVID-19 Treatment

NCT04403555 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 164

Last updated 2021-08-02

No results posted yet for this study

Summary

Efficacy of Ivermectin in COVID-19 treatment

Conditions

Interventions

DRUG

Ivermectin

Ivermectin treatment

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • sherief Abd-Elsalam, Ass. Prof. · ass. Prof. Tropical Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2020-10-31
Completion
2020-12-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04403555 on ClinicalTrials.gov